nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—SDC4—lung cancer	0.0425	0.105	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—AKR1C1—lung cancer	0.0319	0.0784	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—SDC4—lung cancer	0.0217	0.0534	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—AKR1C1—lung cancer	0.0163	0.04	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—APOA1—lung cancer	0.0132	0.0325	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—APOA1—lung cancer	0.0113	0.0278	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.00967	0.0238	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—ALB—lung cancer	0.00894	0.022	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Crizotinib—lung cancer	0.0083	0.014	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Pemetrexed—lung cancer	0.00758	0.0128	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Gefitinib—lung cancer	0.00754	0.0127	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.00733	0.018	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—APOA1—lung cancer	0.00675	0.0166	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Crizotinib—lung cancer	0.00664	0.0112	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Pemetrexed—lung cancer	0.00607	0.0102	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Gefitinib—lung cancer	0.00603	0.0102	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Crizotinib—lung cancer	0.00596	0.01	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Crizotinib—lung cancer	0.00589	0.00992	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Crizotinib—lung cancer	0.00585	0.00985	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Crizotinib—lung cancer	0.00584	0.00984	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.0057	0.014	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Pemetrexed—lung cancer	0.00545	0.00918	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Pemetrexed—lung cancer	0.00538	0.00907	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Gefitinib—lung cancer	0.00535	0.00901	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Pemetrexed—lung cancer	0.00534	0.009	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Pemetrexed—lung cancer	0.00534	0.00899	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Gefitinib—lung cancer	0.00531	0.00895	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Gefitinib—lung cancer	0.0053	0.00893	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Pemetrexed—lung cancer	0.00506	0.00853	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Gefitinib—lung cancer	0.00503	0.00847	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Pemetrexed—lung cancer	0.00489	0.00824	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Gefitinib—lung cancer	0.00486	0.00819	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Crizotinib—lung cancer	0.00486	0.00819	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Crizotinib—lung cancer	0.00463	0.00781	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Topotecan—lung cancer	0.00455	0.00767	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Erlotinib—lung cancer	0.00451	0.00759	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Crizotinib—lung cancer	0.00448	0.00755	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Pemetrexed—lung cancer	0.00444	0.00748	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Erlotinib—lung cancer	0.00444	0.00748	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Gefitinib—lung cancer	0.00441	0.00744	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Teniposide—lung cancer	0.00436	0.00734	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Crizotinib—lung cancer	0.00431	0.00726	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—COL4A3BP—lung cancer	0.00431	0.0106	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AZIN2—lung cancer	0.00431	0.0106	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Crizotinib—lung cancer	0.00427	0.0072	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Crizotinib—lung cancer	0.00427	0.00719	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Pemetrexed—lung cancer	0.00424	0.00714	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Gefitinib—lung cancer	0.00421	0.00709	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Teniposide—lung cancer	0.0041	0.00691	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Pemetrexed—lung cancer	0.00409	0.0069	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Crizotinib—lung cancer	0.00402	0.00678	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.00401	0.00988	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal discomfort—Cisplatin—lung cancer	0.00401	0.00676	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Paclitaxel—lung cancer	0.00397	0.00669	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Teniposide—lung cancer	0.00396	0.00668	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Pemetrexed—lung cancer	0.00394	0.00663	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Gefitinib—lung cancer	0.00391	0.00659	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Pemetrexed—lung cancer	0.0039	0.00658	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Pemetrexed—lung cancer	0.0039	0.00657	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Vinorelbine—lung cancer	0.0039	0.00656	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.00389	0.00956	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Gefitinib—lung cancer	0.00388	0.00653	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Gefitinib—lung cancer	0.00387	0.00653	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Pemetrexed—lung cancer	0.00368	0.00619	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ATP5H—lung cancer	0.00366	0.00901	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Gefitinib—lung cancer	0.00365	0.00616	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Topotecan—lung cancer	0.00364	0.00614	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Erlotinib—lung cancer	0.00361	0.00608	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Teniposide—lung cancer	0.0036	0.00606	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Teniposide—lung cancer	0.00343	0.00578	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Docetaxel—lung cancer	0.00337	0.00567	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.00336	0.00828	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Vinblastine—lung cancer	0.00333	0.0056	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Topotecan—lung cancer	0.00327	0.00551	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PLBD1—lung cancer	0.00326	0.00803	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Erlotinib—lung cancer	0.00324	0.00545	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Topotecan—lung cancer	0.00323	0.00544	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.00321	0.00789	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Topotecan—lung cancer	0.00321	0.00541	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Topotecan—lung cancer	0.0032	0.0054	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Erlotinib—lung cancer	0.0032	0.00539	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Teniposide—lung cancer	0.00319	0.00537	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Erlotinib—lung cancer	0.00317	0.00535	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Erlotinib—lung cancer	0.00317	0.00534	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Irinotecan—lung cancer	0.00317	0.00533	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Teniposide—lung cancer	0.00316	0.00533	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Teniposide—lung cancer	0.00316	0.00532	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Teniposide—lung cancer	0.00314	0.00529	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Vinblastine—lung cancer	0.00313	0.00527	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Vinorelbine—lung cancer	0.00312	0.00525	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Topotecan—lung cancer	0.00304	0.00512	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Vinblastine—lung cancer	0.00302	0.0051	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Erlotinib—lung cancer	0.00301	0.00507	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HSD17B10—lung cancer	0.00298	0.00734	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Teniposide—lung cancer	0.00298	0.00502	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PGAM1—lung cancer	0.00295	0.00726	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Topotecan—lung cancer	0.00294	0.00495	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Cisplatin—lung cancer	0.00292	0.00491	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Erlotinib—lung cancer	0.00291	0.0049	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Cisplatin—lung cancer	0.00287	0.00484	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CKB—lung cancer	0.00277	0.00682	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Vinorelbine—lung cancer	0.00276	0.00466	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—SDC4—lung cancer	0.00276	0.00678	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Vinblastine—lung cancer	0.00274	0.00462	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Vinorelbine—lung cancer	0.00274	0.00462	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Vinorelbine—lung cancer	0.00274	0.00462	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AXL—lung cancer	0.00273	0.00671	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Topotecan—lung cancer	0.00267	0.00449	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Erlotinib—lung cancer	0.00264	0.00444	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Paclitaxel—lung cancer	0.00262	0.00441	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Vinblastine—lung cancer	0.00262	0.00441	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CNDP2—lung cancer	0.00261	0.00642	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTM2—lung cancer	0.00261	0.00642	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Vinorelbine—lung cancer	0.0026	0.00438	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Paclitaxel—lung cancer	0.00258	0.00435	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Irinotecan—lung cancer	0.00257	0.00433	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Topotecan—lung cancer	0.00254	0.00428	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MTMR3—lung cancer	0.00254	0.00624	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Vinblastine—lung cancer	0.00253	0.00426	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Erlotinib—lung cancer	0.00252	0.00424	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Vinorelbine—lung cancer	0.00251	0.00423	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Gemcitabine—lung cancer	0.0025	0.00422	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PGAM1—lung cancer	0.00247	0.00608	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Topotecan—lung cancer	0.00246	0.00414	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Vinblastine—lung cancer	0.00243	0.0041	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Erlotinib—lung cancer	0.00243	0.0041	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—SKI—lung cancer	0.00243	0.00598	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Vinblastine—lung cancer	0.0024	0.00404	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Topotecan—lung cancer	0.00236	0.00398	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—B4GALT5—lung cancer	0.00236	0.00581	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP2A7—lung cancer	0.00236	0.0058	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Topotecan—lung cancer	0.00234	0.00395	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Topotecan—lung cancer	0.00234	0.00394	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Erlotinib—lung cancer	0.00234	0.00394	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Cisplatin—lung cancer	0.00233	0.00393	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Topotecan—lung cancer	0.00233	0.00392	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Erlotinib—lung cancer	0.00232	0.00391	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Erlotinib—lung cancer	0.00232	0.0039	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SDC4—lung cancer	0.00231	0.00568	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Irinotecan—lung cancer	0.00231	0.00389	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Erlotinib—lung cancer	0.0023	0.00388	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Vinorelbine—lung cancer	0.00228	0.00384	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Irinotecan—lung cancer	0.00228	0.00384	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Vinblastine—lung cancer	0.00227	0.00383	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Irinotecan—lung cancer	0.00226	0.00381	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Irinotecan—lung cancer	0.00226	0.00381	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Docetaxel—lung cancer	0.00222	0.00374	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Gemcitabine—lung cancer	0.00222	0.00374	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Topotecan—lung cancer	0.00221	0.00372	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Gemcitabine—lung cancer	0.0022	0.00372	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Methotrexate—lung cancer	0.0022	0.00371	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Gemcitabine—lung cancer	0.0022	0.00371	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Erlotinib—lung cancer	0.00218	0.00368	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Vinorelbine—lung cancer	0.00218	0.00366	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Irinotecan—lung cancer	0.00214	0.00361	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—COL4A2—lung cancer	0.00212	0.00522	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PXN—lung cancer	0.00211	0.00519	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—RRM1—lung cancer	0.0021	0.00517	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTA3—lung cancer	0.0021	0.00517	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Vinorelbine—lung cancer	0.0021	0.00354	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Doxorubicin—lung cancer	0.0021	0.00354	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Paclitaxel—lung cancer	0.0021	0.00353	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Irinotecan—lung cancer	0.00207	0.00349	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Cisplatin—lung cancer	0.00207	0.00349	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GIPR—lung cancer	0.00207	0.00509	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKR1C1—lung cancer	0.00207	0.00509	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Cisplatin—lung cancer	0.00206	0.00346	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Vinorelbine—lung cancer	0.00202	0.00341	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Vinorelbine—lung cancer	0.002	0.00338	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Vinorelbine—lung cancer	0.002	0.00337	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Vinorelbine—lung cancer	0.00199	0.00336	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—B4GALT5—lung cancer	0.00198	0.00486	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SDC4—lung cancer	0.00193	0.00475	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTA4—lung cancer	0.00192	0.00473	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NPPA—lung cancer	0.0019	0.00468	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Etoposide—lung cancer	0.0019	0.00319	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—DUSP3—lung cancer	0.00189	0.00465	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Vinorelbine—lung cancer	0.00189	0.00318	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Etoposide—lung cancer	0.00188	0.00317	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Paclitaxel—lung cancer	0.00188	0.00317	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Irinotecan—lung cancer	0.00188	0.00317	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Etoposide—lung cancer	0.00188	0.00317	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.00188	0.00462	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTA2—lung cancer	0.00187	0.00461	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Paclitaxel—lung cancer	0.00186	0.00313	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PPIA—lung cancer	0.00186	0.00457	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RHEB—lung cancer	0.00185	0.00456	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00185	0.00311	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Paclitaxel—lung cancer	0.00184	0.00311	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ALDOA—lung cancer	0.00184	0.00453	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Gemcitabine—lung cancer	0.00183	0.00309	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTA1—lung cancer	0.00181	0.00445	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Irinotecan—lung cancer	0.00179	0.00302	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCC3—lung cancer	0.00179	0.0044	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Etoposide—lung cancer	0.00178	0.003	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Docetaxel—lung cancer	0.00178	0.00299	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GRM8—lung cancer	0.00176	0.00432	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Paclitaxel—lung cancer	0.00175	0.00295	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Gemcitabine—lung cancer	0.00175	0.00294	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ADCY1—lung cancer	0.00174	0.00428	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Irinotecan—lung cancer	0.00173	0.00292	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKR1C1—lung cancer	0.00173	0.00426	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Etoposide—lung cancer	0.00172	0.0029	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Cisplatin—lung cancer	0.00171	0.00288	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ENO2—lung cancer	0.00171	0.0042	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SKI—lung cancer	0.0017	0.00419	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PPP2R1B—lung cancer	0.0017	0.00417	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SMARCA4—lung cancer	0.0017	0.00417	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Paclitaxel—lung cancer	0.00169	0.00285	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—UGT1A1—lung cancer	0.00168	0.00413	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Irinotecan—lung cancer	0.00167	0.00281	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Irinotecan—lung cancer	0.00165	0.00279	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Irinotecan—lung cancer	0.00165	0.00278	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Irinotecan—lung cancer	0.00164	0.00277	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Cisplatin—lung cancer	0.00163	0.00274	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Gemcitabine—lung cancer	0.00162	0.00274	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GNG11—lung cancer	0.00162	0.00399	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOA1—lung cancer	0.00161	0.00397	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Gemcitabine—lung cancer	0.00161	0.00271	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Gemcitabine—lung cancer	0.00161	0.00271	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Methotrexate—lung cancer	0.0016	0.0027	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Gemcitabine—lung cancer	0.0016	0.0027	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Docetaxel—lung cancer	0.0016	0.00269	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Docetaxel—lung cancer	0.00158	0.00265	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Docetaxel—lung cancer	0.00156	0.00264	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Etoposide—lung cancer	0.00156	0.00264	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Docetaxel—lung cancer	0.00156	0.00263	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Irinotecan—lung cancer	0.00156	0.00262	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ENO1—lung cancer	0.00155	0.00382	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALDOA—lung cancer	0.00154	0.0038	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Paclitaxel—lung cancer	0.00153	0.00258	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Gemcitabine—lung cancer	0.00152	0.00256	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Cisplatin—lung cancer	0.00151	0.00255	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Cisplatin—lung cancer	0.0015	0.00253	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Cisplatin—lung cancer	0.0015	0.00253	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NCOA3—lung cancer	0.0015	0.00369	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Etoposide—lung cancer	0.00149	0.00251	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Docetaxel—lung cancer	0.00148	0.0025	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PXN—lung cancer	0.00148	0.00364	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	0.00147	0.00362	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Paclitaxel—lung cancer	0.00146	0.00247	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ADCY1—lung cancer	0.00146	0.00359	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCG2—lung cancer	0.00146	0.00359	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKR1C1—lung cancer	0.00145	0.00356	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—OXTR—lung cancer	0.00145	0.00356	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GRP—lung cancer	0.00145	0.00356	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Etoposide—lung cancer	0.00144	0.00243	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—APP—lung cancer	0.00144	0.00355	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Docetaxel—lung cancer	0.00143	0.00241	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—FGF9—lung cancer	0.00143	0.00352	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HPGDS—lung cancer	0.00143	0.00352	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ENO2—lung cancer	0.00143	0.00352	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPP2R1B—lung cancer	0.00142	0.00349	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Paclitaxel—lung cancer	0.00141	0.00238	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Cisplatin—lung cancer	0.00141	0.00238	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—POMC—lung cancer	0.0014	0.00345	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Etoposide—lung cancer	0.00139	0.00234	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTT1—lung cancer	0.00139	0.00341	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Doxorubicin—lung cancer	0.00139	0.00234	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Etoposide—lung cancer	0.00138	0.00232	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Etoposide—lung cancer	0.00137	0.00231	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GCLC—lung cancer	0.00137	0.00337	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP2A6—lung cancer	0.00137	0.00337	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Etoposide—lung cancer	0.00137	0.0023	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Doxorubicin—lung cancer	0.00137	0.0023	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—JUNB—lung cancer	0.00137	0.00336	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	0.00136	0.00336	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Paclitaxel—lung cancer	0.00136	0.00229	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GNG11—lung cancer	0.00136	0.00333	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Paclitaxel—lung cancer	0.00135	0.00227	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Paclitaxel—lung cancer	0.00135	0.00227	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Paclitaxel—lung cancer	0.00134	0.00226	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Docetaxel—lung cancer	0.0013	0.00219	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ENO1—lung cancer	0.0013	0.0032	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Etoposide—lung cancer	0.0013	0.00218	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	0.00129	0.00318	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VEGFC—lung cancer	0.00129	0.00317	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Methotrexate—lung cancer	0.00128	0.00216	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ALB—lung cancer	0.00128	0.00314	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Paclitaxel—lung cancer	0.00127	0.00214	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Docetaxel—lung cancer	0.00124	0.00209	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADCY1—lung cancer	0.00122	0.003	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Docetaxel—lung cancer	0.0012	0.00202	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—FOXO3—lung cancer	0.0012	0.00294	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PPP2R1B—lung cancer	0.00119	0.00292	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SMARCA4—lung cancer	0.00119	0.00292	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP2E1—lung cancer	0.00117	0.00287	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Docetaxel—lung cancer	0.00115	0.00194	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NQO1—lung cancer	0.00115	0.00283	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Methotrexate—lung cancer	0.00115	0.00194	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HSPB1—lung cancer	0.00115	0.00282	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Docetaxel—lung cancer	0.00114	0.00193	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Docetaxel—lung cancer	0.00114	0.00192	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Methotrexate—lung cancer	0.00114	0.00191	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Docetaxel—lung cancer	0.00114	0.00191	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTHLH—lung cancer	0.00113	0.00279	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	0.00113	0.00278	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Methotrexate—lung cancer	0.00113	0.0019	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Methotrexate—lung cancer	0.00113	0.0019	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	0.00112	0.00275	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Doxorubicin—lung cancer	0.00111	0.00187	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Docetaxel—lung cancer	0.00108	0.00181	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Methotrexate—lung cancer	0.00107	0.0018	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ANXA1—lung cancer	0.00107	0.00262	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HES1—lung cancer	0.00106	0.00261	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—STK11—lung cancer	0.00104	0.00255	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Methotrexate—lung cancer	0.00103	0.00174	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FLT1—lung cancer	0.00103	0.00254	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOTCH3—lung cancer	0.00101	0.00248	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APP—lung cancer	0.00101	0.00248	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGF9—lung cancer	0.001	0.00246	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Doxorubicin—lung cancer	0.000996	0.00168	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ERCC2—lung cancer	0.000991	0.00244	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Doxorubicin—lung cancer	0.000983	0.00166	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000977	0.00165	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Doxorubicin—lung cancer	0.000975	0.00164	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTEN—lung cancer	0.000975	0.0024	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ERBB3—lung cancer	0.000969	0.00238	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTP1—lung cancer	0.000961	0.00236	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—JUNB—lung cancer	0.000956	0.00235	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Methotrexate—lung cancer	0.000937	0.00158	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CAT—lung cancer	0.000935	0.0023	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—EP300—lung cancer	0.00093	0.00229	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TERT—lung cancer	0.000929	0.00229	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Doxorubicin—lung cancer	0.000925	0.00156	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCB1—lung cancer	0.000909	0.00224	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FGFR1—lung cancer	0.000902	0.00222	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Doxorubicin—lung cancer	0.000894	0.00151	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Methotrexate—lung cancer	0.000894	0.00151	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—TYMS—lung cancer	0.000893	0.0022	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HIF1A—lung cancer	0.000889	0.00219	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTM1—lung cancer	0.000883	0.00217	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STK11—lung cancer	0.000868	0.00214	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Methotrexate—lung cancer	0.000864	0.00146	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—APOA1—lung cancer	0.000857	0.00211	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FOXO3—lung cancer	0.000838	0.00206	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP1A1—lung cancer	0.000837	0.00206	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Methotrexate—lung cancer	0.000831	0.0014	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ERCC2—lung cancer	0.00083	0.00204	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Methotrexate—lung cancer	0.000824	0.00139	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Methotrexate—lung cancer	0.000823	0.00139	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Methotrexate—lung cancer	0.000818	0.00138	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Doxorubicin—lung cancer	0.000812	0.00137	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AVP—lung cancer	0.000785	0.00193	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—KIT—lung cancer	0.000783	0.00193	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APC—lung cancer	0.000783	0.00193	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Methotrexate—lung cancer	0.000776	0.00131	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Doxorubicin—lung cancer	0.000774	0.0013	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—EGF—lung cancer	0.000774	0.0019	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IGF1R—lung cancer	0.000756	0.00186	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Doxorubicin—lung cancer	0.000748	0.00126	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HES1—lung cancer	0.000743	0.00183	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—BRAF—lung cancer	0.000736	0.00181	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6R—lung cancer	0.000727	0.00179	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CREBBP—lung cancer	0.000726	0.00179	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Doxorubicin—lung cancer	0.000719	0.00121	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOA1—lung cancer	0.000718	0.00177	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Doxorubicin—lung cancer	0.000713	0.0012	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Doxorubicin—lung cancer	0.000713	0.0012	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Doxorubicin—lung cancer	0.000709	0.00119	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—MAP2K1—lung cancer	0.000693	0.0017	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CD—lung cancer	0.000688	0.00169	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	0.000688	0.00169	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ERBB3—lung cancer	0.000679	0.00167	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Doxorubicin—lung cancer	0.000672	0.00113	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CG—lung cancer	0.000656	0.00161	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TERT—lung cancer	0.000651	0.0016	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGFR1—lung cancer	0.000632	0.00155	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—POMC—lung cancer	0.000624	0.00154	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HIF1A—lung cancer	0.000622	0.00153	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MDM2—lung cancer	0.000617	0.00152	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—RAF1—lung cancer	0.000614	0.00151	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CREBBP—lung cancer	0.000608	0.0015	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ERBB2—lung cancer	0.000608	0.0015	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOA1—lung cancer	0.0006	0.00148	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CB—lung cancer	0.0006	0.00148	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MTOR—lung cancer	0.0006	0.00148	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CD4—lung cancer	0.000599	0.00147	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KDR—lung cancer	0.000595	0.00146	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTGS2—lung cancer	0.000594	0.00146	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CD—lung cancer	0.000576	0.00142	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALB—lung cancer	0.000569	0.0014	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KIT—lung cancer	0.000548	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APC—lung cancer	0.000548	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CG—lung cancer	0.000548	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EGF—lung cancer	0.000542	0.00133	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—POMC—lung cancer	0.000522	0.00128	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN1A—lung cancer	0.00052	0.00128	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTEN—lung cancer	0.000518	0.00128	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—BRAF—lung cancer	0.000515	0.00127	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6R—lung cancer	0.000509	0.00125	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CREBBP—lung cancer	0.000508	0.00125	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CB—lung cancer	0.000502	0.00124	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTGS2—lung cancer	0.000498	0.00122	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—EP300—lung cancer	0.000494	0.00122	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAP2K1—lung cancer	0.000485	0.00119	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CD—lung cancer	0.000482	0.00119	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SRC—lung cancer	0.000481	0.00118	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—STAT3—lung cancer	0.000464	0.00114	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NRAS—lung cancer	0.000462	0.00114	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MAPK3—lung cancer	0.000443	0.00109	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTEN—lung cancer	0.000434	0.00107	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MDM2—lung cancer	0.000432	0.00106	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MYC—lung cancer	0.000431	0.00106	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RAF1—lung cancer	0.00043	0.00106	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ERBB2—lung cancer	0.000426	0.00105	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—EGFR—lung cancer	0.000421	0.00104	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MTOR—lung cancer	0.00042	0.00103	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CB—lung cancer	0.00042	0.00103	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—EP300—lung cancer	0.000414	0.00102	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL8—lung cancer	0.000404	0.000993	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—KRAS—lung cancer	0.000398	0.000979	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CASP3—lung cancer	0.000386	0.00095	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL2—lung cancer	0.000386	0.000949	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCND1—lung cancer	0.000376	0.000925	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—JUN—lung cancer	0.000375	0.000923	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CA—lung cancer	0.000366	0.0009	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MMP9—lung cancer	0.000365	0.000898	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN1A—lung cancer	0.000364	0.000895	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTEN—lung cancer	0.000363	0.000893	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EP300—lung cancer	0.000346	0.000852	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HRAS—lung cancer	0.000338	0.000832	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SRC—lung cancer	0.000337	0.000828	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VEGFA—lung cancer	0.000328	0.000807	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STAT3—lung cancer	0.000325	0.000799	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NRAS—lung cancer	0.000324	0.000797	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6—lung cancer	0.000324	0.000797	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAPK3—lung cancer	0.00031	0.000763	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CA—lung cancer	0.000306	0.000753	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MYC—lung cancer	0.000302	0.000742	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT1—lung cancer	0.000299	0.000735	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EGFR—lung cancer	0.000295	0.000726	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KRAS—lung cancer	0.000279	0.000686	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CA—lung cancer	0.000256	0.00063	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKT1—lung cancer	0.00025	0.000615	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TP53—lung cancer	0.000248	0.000609	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HRAS—lung cancer	0.000237	0.000583	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6—lung cancer	0.000227	0.000558	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT1—lung cancer	0.000209	0.000515	CbGpPWpGaD
